Table 2:
Staging and Pathologic Outcomes for Cancer Patients
| n=121 | |
|---|---|
|
| |
| Pretherapy clinical stage | |
| I | 20 (16.5) |
| II | 19 (15.7) |
| III | 52 (42.0) |
| IVA | 9 (7.4) |
| Unknown | 21 (17.4) |
| Diagnosis | |
| Adenocarcinoma | 114 (94.2) |
| Squamous cell carcinoma | 6 (5.0) |
| Adenosquamous carcinoma | 1 (0.8) |
| Neoadjuvant Therapy | |
| Chemoradiation | 80 (66.1) |
| Chemotherapy | 7 (5.8) |
| None | 31 (25.6) |
| Other/Unknown | 3 (2.5) |
| Pathology | |
| T stage | |
| T0 | 18(14.9) |
| Tis | 3(2.5) |
| T1 | 38(31.4) |
| T2 | 17 (14.0) |
| T3 | 44 (36.4) |
| T4 | 0 |
| Unknown | 1 (0.8) |
| N stage | |
| N0 | 81(66.1) |
| N1 | 25(21.4) |
| N2 | 10(6.3) |
| N3 | 2(0.9) |
| Unknown | 3 (2.7) |
| Number of nodes retrieved | 15.5 [12.0,22.0] |
| Margin negative | 99/105 (94.3) |
| Treatment effect grade | n=63 |
| 0 (complete) | 12 (19.0) |
| 1 (moderate) | 17 (27.0) |
| 2 (minimal) | 26 (41.3) |
| 3 (poor) | 4 (6.3) |
| Response not graded | 4 (6.3) |
Reported as number (percent) or median [IQR]. If data were not available for the entire cohort, reported as number/total (percent).